Sugarlo 50/ Plus 500 Mg 30 Tablets

Sugarlo 50/ Plus 500 Mg 30 Tablets

Description:

Sugarlo Plus 50/500 mg 30 film-coated tablets is an oral anti-diabetic prescription medicine used for the management of type 2 diabetes mellitus. It combines two active ingredients, vildagliptin and metformin hydrochloride, to help control blood glucose levels in adults when diet, exercise, and metformin alone are not sufficient. Sugarlo Plus belongs to the class of DPP-4 inhibitors (vildagliptin) and biguanides (metformin), providing complementary mechanisms of action to improve glycemic control and support long-term diabetes management.

Indications:

• Management of type 2 diabetes mellitus in adults, particularly when blood glucose is not adequately controlled by metformin alone, diet, and exercise.
• Helps reduce elevated fasting blood glucose levels.
• Helps control postprandial (after-meal) blood glucose spikes.
• May be used as part of combination therapy under medical supervision in patients requiring dual oral therapy.

Active Ingredients / Key Components:

• Vildagliptin – 50 mg per tablet (dpp-4 inhibitor).
• Metformin hydrochloride – 500 mg per tablet (biguanide oral anti-diabetic).
• Other excipients: film-coating and tablet core excipients (full excipient list is not available in the provided information).

Dosage & Administration / How to Use:

• Use only as prescribed by your physician and follow the instructions on the package insert.
• Typical adult dose (general guidance, may vary by patient): usually 1 tablet taken once or twice daily, depending on the physician’s recommendation and previous diabetes treatment regimen.
• Tablets should generally be taken with meals to reduce gastrointestinal side effects associated with metformin (such as nausea or abdominal discomfort).
• Swallow the tablet whole with a glass of water; do not crush or chew unless your doctor or pharmacist advises otherwise.
• Your doctor may adjust the dose based on blood glucose response, kidney function, and tolerance to treatment.
• Do not exceed the prescribed dose and do not stop taking the medicine without consulting your healthcare provider.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.

Clinical Benefits:

• Provides dual mechanism of action: vildagliptin enhances incretin activity to increase insulin secretion and reduce glucagon when blood glucose is high, while metformin reduces hepatic glucose production and improves peripheral glucose uptake.
• Helps achieve better overall glycemic control (lower fasting and postprandial blood glucose levels) in adults with type 2 diabetes.
• Supports long-term management of type 2 diabetes when combined with a healthy diet and regular physical activity.
• Metformin component may contribute to improved lipid profile and weight neutrality in many patients compared with some other anti-diabetic agents.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to vildagliptin, metformin hydrochloride, or any of the excipients.
• Contraindicated in patients with severe renal impairment or significant reduction in kidney function, due to increased risk of lactic acidosis from metformin.
• Contraindicated in acute conditions that may alter kidney function or cause tissue hypoxia (e.g., severe infection, shock, dehydration, acute heart failure, respiratory failure).
• Not recommended in patients with severe hepatic impairment or active liver disease; vildagliptin may affect liver enzymes and requires monitoring.
• Use with caution in elderly patients and those with risk factors for lactic acidosis (e.g., renal impairment, congestive heart failure, alcohol abuse).
• Avoid excessive alcohol intake (acute or chronic) during treatment, as it increases the risk of lactic acidosis with metformin.
• Temporary discontinuation may be required before iodinated contrast imaging procedures or major surgery, as advised by your doctor.
• Monitor liver function tests periodically as recommended by your physician during treatment with vildagliptin-containing products.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety in pregnancy and lactation requires medical evaluation and may require switching to insulin.
• Consult your doctor before use if you have kidney disease, liver disease, heart failure, history of pancreatitis, or any serious chronic medical condition.
• Not intended for use in type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
• Keep out of reach of children.

Side Effects:

• Common side effects (usually mild to moderate): nausea, vomiting, diarrhea, abdominal pain, loss of appetite, headache, dizziness, and mild gastrointestinal discomfort, mainly related to metformin.
• Possible side effects related to vildagliptin: headache, dizziness, mild upper respiratory symptoms, and rarely joint pain.
• Metformin may rarely cause lactic acidosis, a serious but potentially life-threatening condition characterized by rapid breathing, severe weakness, abdominal pain, irregular heartbeat, and feeling very unwell; seek immediate medical attention if these occur.
• Rare but serious side effects: pancreatitis (severe, persistent abdominal pain that may radiate to the back, often with nausea and vomiting), severe skin reactions, or significant liver enzyme elevation; stop the medicine and contact your doctor immediately if these symptoms appear.
• If you experience signs of allergic reaction (rash, itching, swelling of face or throat, severe dizziness, difficulty breathing), seek emergency medical help.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: oral anti-diabetic medicine.
• Form: film-coated tablet.
• Strength per tablet: vildagliptin 50 mg + metformin hydrochloride 500 mg.
• Pack size: 30 film-coated tablets per pack.
• Intended use: adult patients with type 2 diabetes mellitus as prescribed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.